Strain Profile
Save

Eubacterium siraeum

◔ Human-origin
Sequenced
Public genome assembly available

Eubacterium siraeum (recently also classified as Ruminiclostridium siraeum) is an obligate anaerobe and gut commensal found in the human and animal intestinal microbiota, where it participates in fiber fermentation and butyrate production. Observational studies have examined its abundance in relation to metabolic phenotypes, and animal studies have examined fat deposition and tyrosine-related signaling in high-fat diet mice, as well as culture conditions and potential probiotic delivery methods. E. siraeum is not a commercial probiotic, and its obligate anaerobic nature makes formulation technically challenging. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.

Where it's been studied

Share of this strain's 26 body-system-tagged papers that concern each system. Research coverage, not measured effect.

+1 more systems

Symptoms in the research

Share of this strain's 8 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

Research

82 papers reference this strain in the probiotic database.

Match confidence
2026 OTHER
Eubacterium siraeum Moore et al. 1976
· BacDive
2024 OBSERVATIONAL
Impact of CBM588 on gut microbiome composition and dysbiosis in patients receiving frontline immune checkpoint inhibitor (ICI) combinations for metastatic renal cell carcinoma (mRCC).
· Journal of Clinical Oncology
2024 ANIMAL
Eubacterium siraeum suppresses fat deposition via decreasing the tyrosine-mediated PI3K/AKT signaling pathway in high-fat diet-induced obesity
· Microbiome
2022 ANIMAL
Impact of Modular Architecture on Activity of Glycoside Hydrolase Family 5 Subfamily 8 Mannanases
· Molecules
2017 ANIMAL
Investigation Of Optimal Culture Conditions And Development Of A Protective Delivery Method Of Eubacterium Siraeum As A Potential Probiotic
· DigitalCommons - WayneState (Wayne State University)
2010 OTHER
Exemplar Abstract for Ruminiclostridium siraeum (Moore et al. 1976) Yutin and Galperin 2013 and Eubacterium siraeum Moore et al. 1976 (Approved Lists 1980).
· The NamesforLife Abstracts
1976 OTHER
Emendation of Bacteroidaceae and Butyrivibrio and Descriptions of Desulfomonas gen. nov. and Ten New Species in the Genera Desulfomonas, Butyrivibrio, Eubacterium, Clostridium, and Ruminococcus
· International Journal of Systematic Bacteriology
2026 ANIMAL
Effects of Galacto-Oligosaccharide Supplementation on Cecal Microbiota, Phospholipid and Aromatic Amino Acid Metabolism in Mice
· Microorganisms
2026 ANIMAL
Abstract LB083: Gut microbiome signatures of survival and immunotherapy response in advanced thyroid cancer
· Cancer Research
2026 ANIMAL
The gut microbiota shapes the human and murine breath volatilome
· Cell Metabolism
2026 OBSERVATIONAL
Causal relationships between Burkholderiales, Eubacteriaceae and colorectal cancer mediated by plasma metabolites
· Revista Argentina de Microbiología
2025 ANIMAL
Medication‐resistant epilepsy is associated with a unique gut microbiota signature
· Epilepsia
2025 WGS
What is the micro- and nanoplastics impact on pathogenic microorganisms?
· Frontiers in Microbiology
2025 ANIMAL
Changes in the gut microbiota in a model of oxaliplatin-induced neuropathic pain in rats
· UCrea (University of Cantabria)
2025 OTHER
Gut microbiome and cognitive function in the Hispanic Community Health Study/Study of Latinos
· Journal of Alzheimer s Disease
2025 WGS
Differences in gut microbiome between autosomal dominant polycystic kidney disease with and without intracranial aneurysms
· Scientific Reports
2025 IN_VITRO
Novel Acylated Naringin Enhances Propionate Release and Stimulates the Growth of Flavanone-Metabolizing Bacteria in an In Vitro Batch Fermentation Model
· Life
2025 ANIMAL
Quzhou Aurantii Fructus Flavonoids Ameliorate Inflammatory Responses, Intestinal Barrier Dysfunction in DSS-Induced Colitis by Modulating PI3K/AKT Signaling Pathway and Gut Microbiome
· Journal of Inflammation Research
2024 RCT
77 Impact of CBM588 on gut microbiome composition and dysbiosis in patients receiving frontline immune checkpoint inhibitor (ICI) combinations for metastatic renal cell carcinoma (mRCC)
· The Oncologist
2024 ANIMAL
Concomitant gut dysbiosis and defective gut barrier serve as the bridges between hypercortisolism and chronic systemic inflammation in Cushing’s disease
· European Journal of Endocrinology
Browse all 82 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.